Hayat Pharmaceutical Industries Co (AMM:HPIC) 3-Year EBITDA Growth Rate : -5.30% (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co 3-Year EBITDA Growth Rate?

Hayat Pharmaceutical Industries Co's EBITDA per Share for the three months ended in Mar. 2024 was JOD0.07.

During the past 12 months, Hayat Pharmaceutical Industries Co's average EBITDA Per Share Growth Rate was -69.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hayat Pharmaceutical Industries Co was 38.50% per year. The lowest was -5.30% per year. And the median was 12.30% per year.

Competitive Comparison of Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate falls into.

Hayat Pharmaceutical Industries Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hayat Pharmaceutical Industries Co (AMM:HPIC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hayat Pharmaceutical Industries Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hayat Pharmaceutical Industries Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hayat Pharmaceutical Industries Co (AMM:HPIC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118

Website

https://www.hayatpharma.com

Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics and initiating marketing campaigns as well as import and export operations. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co (AMM:HPIC) Headlines

No Headlines